AAAAAA

   
Results: 1-7 |
Results: 7
Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate
Authors: Davies, TG Tunnah, P Meijer, L Marko, D Eisenbrand, G Endicott, JA Noble, MEM
Citation: Tg. Davies et al., Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate, STRUCTURE, 9(5), 2001, pp. 389-397
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease - A property common to most cycline-dependent kinase inhibitors?
Authors: Leclerc, S Garnier, M Hoessel, R Marko, D Bibb, JA Snyder, GL Greengard, P Biernat, J Wu, YZ Mandelkow, EM Eisenbrand, G Meijer, L
Citation: S. Leclerc et al., Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease - A property common to most cycline-dependent kinase inhibitors?, J BIOL CHEM, 276(1), 2001, pp. 251-260
The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor
Authors: Meiers, S Kemeny, M Weyand, U Gastpar, R von Angerer, E Marko, D
Citation: S. Meiers et al., The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor, J AGR FOOD, 49(2), 2001, pp. 958-962
Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives inhuman tumour cells
Authors: Marko, D Schatzle, S Friedel, A Genzlinger, A Zankl, H Meijer, L Eisenbrand, G
Citation: D. Marko et al., Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives inhuman tumour cells, BR J CANC, 84(2), 2001, pp. 283-289
Cyclic 3 ',5 '-nucleotide phosphodiesterases: Potential targets for anticancer therapy
Authors: Marko, D Pahlke, G Merz, KH Eisenbrand, G
Citation: D. Marko et al., Cyclic 3 ',5 '-nucleotide phosphodiesterases: Potential targets for anticancer therapy, CHEM RES T, 13(10), 2000, pp. 944-948
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
Authors: Hoessel, R Leclerc, S Endicott, JA Nobel, MEM Lawrie, A Tunnah, P Leost, M Damiens, E Marie, D Marko, D Niederberger, E Tang, WC Eisenbrand, G Meijer, L
Citation: R. Hoessel et al., Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases, NAT CELL BI, 1(1), 1999, pp. 60-67
Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization
Authors: Gastpar, R Goldbrunner, M Marko, D von Angerer, E
Citation: R. Gastpar et al., Methoxy-substituted 3-formyl-2-phenylindoles inhibit tubulin polymerization, J MED CHEM, 41(25), 1998, pp. 4965-4972
Risultati: 1-7 |